FindTrial
Sign In

Effects of remifentanil on cardiovascular responses to endotracheal or aryngeal mask in parturient undergoing caesarean delivery general anaesthesia

Effects of remifentanil on cardiovascular responses to endotracheal or aryngeal mask in parturient undergoing caesarean delivery general anaesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007144
Enrollment
Unknown
Registered
2015-09-27
Start date
2015-09-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean section

Interventions

R1T:remifentanil 0.8mg
R2T:remifentanil 1mg/kg
R3T:remifentanil 1.25mg/kg

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Over 36 gestational weeks, absolute or relative contraindications to regional anesthesia: thrombopenia, spine malformation.

Exclusion criteria

Exclusion criteria: Exact fetal distress, severe preeclampsia (SBP higher than 160mmHg or DBP higher than 110mmHg), cardiorespiratory diseases, neurological disease, known congeital abnormalities or signs of fetal compromise, andbody height shorter than 152cm.

Design outcomes

Primary

MeasureTime frame
Bp;HR;index of consciousness, IOC;Apgar scores;—

Countries

China

Contacts

Public ContactZhang Zhaohang
zzh398@126.com+86 15866718126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026